Nerlynx Neratinib — Carefirst Caremark
5 indications indexed for this drug.
- Early Stage Her2 Positive Breast CancerView coverage criteria
- Her2 Mutant Cervical CancerView coverage criteria
- Her2 Positive Breast Cancer With Brain MetastasesView coverage criteria
- Metastatic Breast Cancer With Her2 Activating MutationsView coverage criteria
- Recurrent Or Metastatic Her2 Positive Breast CancerView coverage criteria